A phase 1 dose escalation and expanded cohort study of P-MUC1C-ALLO1 in adult subjects with advanced or metastatic solid tumors

Disease:

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Renal Cell Carcinoma, Nasopharyngeal Cancer, Head and Neck Squamous Cell Carcinoma, Gastric Cancer

Study phase:

Phase I

Physician name:

Ecaterina Ileana Dumbrava

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-877-421-1842